High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
01 2019
Historique:
received: 18 04 2018
revised: 28 06 2018
accepted: 23 07 2018
pubmed: 25 8 2018
medline: 27 6 2020
entrez: 25 8 2018
Statut: ppublish

Résumé

Although central Africa is classified as having a high endemicity of hepatitis B virus (HBV) and hepatitis D virus (HDV) infection, there is paucity of prevalence studies. For the first time on a country-wide level in Central Africa, we show in Gabon an overall 7.4% prevalence of Hepatitis B surface antigen (HBsAg) and that more than 25% of the HBsAg-positive population are infected by HDV. Although HBV prevalence did not differ significantly between provinces, there is a north-south split in the distribution of HDV seroprevalence, with the highest rates (>66.0%) correlating with the presence of specific ethnic groups in the northeastern provinces. Genotyping revealed high genetic diversity of the HBV and HDV strains circulating in Gabon, including many restricted to this region of the globe. This work confirmed that high exposure to HBV and HDV infection reported in selected regions of Gabon holds true across the whole country.

Identifiants

pubmed: 30141209
doi: 10.1111/jvh.12991
doi:

Substances chimiques

Hepatitis Antibodies 0
RNA, Viral 0

Banques de données

GENBANK
['MH172021', 'MH172151', 'MH363783', 'MH363805']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

170-182

Informations de copyright

© 2018 John Wiley & Sons Ltd.

Auteurs

Soraya Groc (S)

MIVEGEC, IRD/CNRS/Univ. Montpellier, Montpellier, France.

Jessica Lee Abbate (JL)

MIVEGEC, IRD/CNRS/Univ. Montpellier, Montpellier, France.
UMR UMMISCO (UMI 209 IRD-UPMC), Bondy, France.

Frédéric Le Gal (F)

Laboratoire de Microbiologie Clinique, Hôpital Avicenne, Centre National de Référence des Virus des Hépatites B C et Delta, Bobigny, France.
Unité INSERM U955, Equipe 18, Créteil, France.

Athenaïs Gerber (A)

Laboratoire de Microbiologie Clinique, Hôpital Avicenne, Centre National de Référence des Virus des Hépatites B C et Delta, Bobigny, France.

Edouard Tuaillon (E)

Pathogenesis and Control of Chronic Infections, Inserm U1058, University of Montpellier, Montpellier, France.
CHU de Montpellier, Montpellier, France.

Jean-Louis Albert (JL)

Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.

Dieudonné Nkoghé (D)

Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.

Eric M Leroy (EM)

MIVEGEC, IRD/CNRS/Univ. Montpellier, Montpellier, France.
Centre International de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.

Benjamin Roche (B)

MIVEGEC, IRD/CNRS/Univ. Montpellier, Montpellier, France.
UMR UMMISCO (UMI 209 IRD-UPMC), Bondy, France.

Pierre Becquart (P)

MIVEGEC, IRD/CNRS/Univ. Montpellier, Montpellier, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH